Companies habitually overlook reimbursement planning for new offerings.

With companies under relentless pressure to commercialize successful products, meet investor expectations, and grow earnings, it is no surprise that no opportunity for enhancing performance is overlooked. Yet establishing third-party reimbursement remains a poorly understood and often-missed occasion for assuring appropriate product valuation and pricing. Companies that integrate R&D, marketing, and reimbursement strategies are in a better position to understand the likelihood of commercial success and the factors that will drive it.

To this end, Aequitas has created the Reimbursement Roadmap™ series to educate companies on the basics of reimbursement planning and strategy. This solution is offered in conjunction with leading industry associations, professional societies, and others. It is intended for a broad audience that includes senior management and other decision-makers charged with product development and investment. Full and half-day programs are offered at different locations throughout the year.

We also offer the Reimbursement Roadmap™ Workbook to guide readers through the process of obtaining appropriate reimbursement for their products. This stand-alone solution offers valuable insights concerning the timing and requirements for understanding how to plan and execute the reimbursement process. Case studies provide examples of successful and unsuccessful approaches to obtaining reimbursement.

The key to our client service is our ability to integrate our know-how in functional areas with our deep industry knowledge. We work with both large and small companies to identify and develop opportunities to improve performance through commercial planning and roll-out. Contact us or explore our website to learn more about Aequitas.